Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06440148 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Mastocytosis is very rare and highly heterogeneous group of disorders, characterized by the accumulation of clonal mast cells which can infiltrate several organs and tissues. Bones are the most frequent localization of systemic mastocytosis. The aim of our research was to explain the potential role of sclerostin in the pathogenesis of bone disease in mastocytosis.
Trial Details
NCT Number NCT06440148
Lead Sponsor Medical University of Lublin
Conditions
(from sponsor)		 Mastocytosis, Bones
Related terms Mastocytosis, Osteolysis, Osteosclerosis, Sclerosteosis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov